Ultragenyx Pharmaceutical Inc header image

Ultragenyx Pharmaceutical Inc

RARE

Equity

ISIN null / Valor 22860122

NASDAQ (2026-08-24)

USD 25.72-0.43%

Ultragenyx Pharmaceutical Inc
UMushroom community rating:

3.15 12 votes No rating yet

NegativeNeutralPositive

About company

Ultragenyx Pharmaceutical Inc is a biopharmaceutical company that focuses on developing and commercializing innovative treatments for rare and ultra-rare genetic diseases. The company's portfolio includes products such as DOJOLVI® for long-chain fatty acid oxidation disorders and CRYSVITA® for X-linked hypophosphatemia and tumor-induced osteomalacia. Ultragenyx is dedicated to providing patients with life-changing therapies that address unmet medical needs in the rare disease community.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-13.6%1Y

-30.4%3Y

-70.6%5Y

Performance

75.4%1Y

60.2%3Y

57.3%5Y

Volatility

2536 M

Market cap (USD)

1,536,974

Daily traded volume (Shares)

43.045 / 41.53

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.15

12 votes

Performance:

3.50

Innovation:

3.45

Society:

3.43

Nature:

3.20

Hazem Baderon

Malaysia, 20 May 2026

Still consolidating, might be ok for long term

Han Yee Kong

Malaysia, 29 Apr 2026

.

oliver baigel

UK, 09 Nov 2025

a very low performing stock with a high level of risk

EQUITIES OF THE SAME SECTOR

Service Corporation International

Service Corporation International Valor: 969683

Annual Return

-50%0%+50%

Risk level

110

1.13%USD 84.23

Bright Horizons Family Solutions

Bright Horizons Family Solutions Valor: 19920287

Annual Return

-50%0%+50%

Risk level

110

1.65%USD 74.08

Evolent Health Inc

Evolent Health Inc Valor: 28153126

Annual Return

-50%0%+50%

Risk level

110

-0.42%USD 4.72

elf Beauty Inc

elf Beauty Inc Valor: 33775016

Annual Return

-50%0%+50%

Risk level

110

3.93%USD 105.95

Bausch Health Companies Inc

Bausch Health Companies Inc Valor: 42260834

Annual Return

-50%0%+50%

Risk level

110

4.15%USD 6.67

Illumina Inc

Illumina Inc Valor: 1111080

Annual Return

-50%0%+50%

Risk level

110

1.74%USD 223.22

Roivant Sciences Limited

Roivant Sciences Limited Valor: 113331044

Annual Return

-50%0%+50%

Risk level

110

0.17%USD 36.36

Sotera Health Company

Sotera Health Company Valor: 57897071

Annual Return

-50%0%+50%

Risk level

110

-2.04%USD 19.17

Surgery Partners Inc

Surgery Partners Inc Valor: 29308003

Annual Return

-50%0%+50%

Risk level

110

-3.93%USD 13.95

PTC Therapeutics Inc

PTC Therapeutics Inc Valor: 2515234

Annual Return

-50%0%+50%

Risk level

110

1.78%USD 71.06

SIX

FactSet

Clearbit

Logos provided by Clearbit